| Iron metabolism regulates p53 signaling through direct heme-p53 interaction and modulation of p53 localization, stability, and function J Shen, X Sheng, ZN Chang, Q Wu, S Wang, Z Xuan, D Li, Y Wu, Y Shang, ... Cell reports 7 (1), 180-193, 2014 | 217 | 2014 |
| FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor L Ran, Y Chen, J Sher, EWP Wong, D Murphy, JQ Zhang, D Li, K Deniz, ... Cancer discovery 8 (2), 234-251, 2018 | 57 | 2018 |
| Hepatic p38α regulates gluconeogenesis by suppressing AMPK Y Jing, W Liu, H Cao, D Zhang, X Yao, S Zhang, H Xia, D Li, Y Wang, ... Journal of hepatology 62 (6), 1319-1327, 2015 | 46 | 2015 |
| Encyclopedia of tissue engineering and regenerative medicine RL Reis Academic Press, 2019 | 42 | 2019 |
| The m subunit of murine translation initiation factor eIF3 maintains the integrity of the eIF3 complex and is required for embryonic development, homeostasis, and organ size … L Zeng, Y Wan, D Li, J Wu, M Shao, J Chen, L Hui, H Ji, X Zhu Journal of Biological Chemistry 288 (42), 30087-30093, 2013 | 33 | 2013 |
| Hepatic loss of survivin impairs postnatal liver development and promotes expansion of hepatic progenitor cells in mice D Li, J Cen, X Chen, EM Conway, Y Ji, L Hui Hepatology 58 (6), 2109-2121, 2013 | 28 | 2013 |
| Hepatocellular carcinoma repression by TNFα‐mediated synergistic lethal effect of mitosis defect‐induced senescence and cell death sensitization D Li, J Fu, M Du, H Zhang, L Li, J Cen, W Li, X Chen, Y Lin, EM Conway, ... Hepatology 64 (4), 1105-1120, 2016 | 26 | 2016 |
| p38α controls erythroblast enucleation and Rb signaling in stress erythropoiesis SM Schultze, A Mairhofer, D Li, J Cen, H Beug, EF Wagner, L Hui Cell research 22 (3), 539-550, 2012 | 22 | 2012 |
| PRC2-inactivating mutations in cancer enhance cytotoxic response to DNMT1-targeted therapy via enhanced viral mimicry AJ Patel, S Warda, JLV Maag, R Misra, MA Miranda-Román, MR Pachai, ... Cancer discovery 12 (9), 2120-2139, 2022 | 19 | 2022 |
| ETS factors in prostate cancer C Qian, D Li, Y Chen Cancer letters 530, 181-189, 2022 | 18 | 2022 |
| Defining the therapeutic selective dependencies for distinct subtypes of PI3K pathway-altered prostate cancers N Mao, Z Zhang, YS Lee, D Choi, AA Rivera, D Li, C Lee, S Haywood, ... Nature Communications 12 (1), 5053, 2021 | 15 | 2021 |
| Hepatic loss of Borealin impairs postnatal liver development, regeneration, and hepatocarcinogenesis L Li, D Li, F Tian, J Cen, X Chen, Y Ji, L Hui Journal of Biological Chemistry 291 (40), 21137-21147, 2016 | 14 | 2016 |
| High-throughput screening for Survivin and Borealin interaction inhibitors in hepatocellular carcinoma L Yue, L Li, D Li, Z Yang, S Han, M Chen, S Lan, X Xu, L Hui Biochemical and biophysical research communications 484 (3), 642-647, 2017 | 12 | 2017 |
| Hybrid hepatocyte: a newly identified player for regeneration in hepatic injuries D Li, W Li, L Hui Hepatology 64 (6), 2244-2246, 2016 | 12 | 2016 |
| ETV4 mediates dosage-dependent prostate tumor initiation and cooperates with p53 loss to generate prostate cancer D Li, Y Zhan, N Wang, F Tang, CJ Lee, G Bayshtok, AR Moore, ... Science Advances 9 (14), eadc9446, 2023 | 2 | 2023 |
| Sex differences orchestrated by androgens at single-cell resolution F Li, X Xing, Q Jin, XM Wang, P Dai, M Han, H Shi, Z Zhang, X Shao, ... Nature, 1-8, 2024 | 1 | 2024 |
| BET inhibitors as a therapeutic intervention in gastrointestinal gene signature-positive castration-resistant prostate cancer. S Shukla, D Li, H Nguyen, J Conner, G Bayshtok, WH Cho, M Pachai, ... bioRxiv, 2024.03. 09.584256, 2024 | | 2024 |
| Abstract B003: Inactivation mutations of Kmt2c/d license a molecular “field effect” and prime the urothelium for tumorigenesis N Wang, MR Pachai, D Li, C Lee, S Warda, G Xie, C Qian, WPE Wong, ... Cancer Research 82 (23_Supplement_2), B003-B003, 2022 | | 2022 |
| PRC2 inactivating mutations amplify cell death in response to DNMT1-targeted therapy through enhanced viral mimicry in malignant peripheral nerve sheath tumor. P Chi, AJ Patel, S Warda, JLV Maag, R Misra, MA Miranda-Roman, ... CLINICAL CANCER RESEARCH 28 (18), 4-5, 2022 | | 2022 |
| Abstract PR005: PRC2 inactivating mutations amplify cell death in response to DNMT1-targeted therapy through enhanced viral mimicry in malignant peripheral nerve sheath tumor P Chi, AJ Patel, S Warda, JLV Maag, R Misra, MA Miranda-Román, ... Clinical Cancer Research 28 (18_Supplement), PR005-PR005, 2022 | | 2022 |
Lijian HuiShanghai Institute of Biochemistry and Cell BiologyVerified email at sibcb.ac.cn
